Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: E9B2W5
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 7 |
GO:0005515 | protein binding | 2 | 7 |
GO:0046982 | protein heterodimerization activity | 4 | 7 |
GO:0046983 | protein dimerization activity | 3 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 54 | 56 | PF00675 | 0.503 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.567 |
CLV_PCSK_KEX2_1 | 54 | 56 | PF00082 | 0.540 |
CLV_PCSK_PC1ET2_1 | 154 | 156 | PF00082 | 0.567 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.576 |
CLV_PCSK_SKI1_1 | 118 | 122 | PF00082 | 0.472 |
CLV_PCSK_SKI1_1 | 96 | 100 | PF00082 | 0.508 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.641 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.608 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.474 |
LIG_14-3-3_CanoR_1 | 125 | 129 | PF00244 | 0.450 |
LIG_FHA_1 | 102 | 108 | PF00498 | 0.417 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.524 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.506 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.463 |
LIG_SUMO_SIM_anti_2 | 104 | 109 | PF11976 | 0.422 |
LIG_UBA3_1 | 145 | 154 | PF00899 | 0.485 |
MOD_CK1_1 | 123 | 129 | PF00069 | 0.524 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.658 |
MOD_CK1_1 | 35 | 41 | PF00069 | 0.614 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.599 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.353 |
MOD_GlcNHglycan | 14 | 18 | PF01048 | 0.650 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.615 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.590 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.615 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.447 |
MOD_GSK3_1 | 35 | 42 | PF00069 | 0.485 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.650 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.577 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.474 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.595 |
MOD_PIKK_1 | 19 | 25 | PF00454 | 0.514 |
MOD_PIKK_1 | 6 | 12 | PF00454 | 0.622 |
MOD_PKA_1 | 118 | 124 | PF00069 | 0.475 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.678 |
MOD_PKA_2 | 124 | 130 | PF00069 | 0.455 |
MOD_Plk_1 | 26 | 32 | PF00069 | 0.495 |
TRG_ER_diArg_1 | 53 | 55 | PF00400 | 0.575 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4KIL7 | Bodo saltans | 33% | 100% |
A0A3S7X5N4 | Leishmania donovani | 87% | 100% |
A4HKH6 | Leishmania braziliensis | 71% | 100% |
A4I803 | Leishmania infantum | 87% | 100% |
Q4Q591 | Leishmania major | 87% | 100% |